Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown

Conclusion: The COVID-19 pandemic has led to a delay in patients receiving anti-VEGF injections. The visual acuity is worse in both treatment naïve as well as those requiring retreatment. This could have long-term impact on vision of patients requiring this vision preserving treatment.

Source: Indian Journal of Ophthalmology - February 17, 2021 Category: Opthalmology Authors: Manavi D Sindal Kanika Chhabra Vaibhav Khanna Source Type: research